Skip to main content
Search
Search
    Quick Search anywhere
    Quick search in Citations
Advanced Search
Skip main navigationClose Drawer MenuOpen Drawer Menu
Next article
Free AccessEditorial

A thought-provoking statement regarding the treatment of patients with peripheral arterial disease

Is there more than just the tip of an iceberg?

Published Online:March 06, 2023https://doi.org/10.1024/0301-1526/a001055
Free first page

References

  • 1 Song P, Rudan D, Zhu Y, Fowkes FJI, Rahimi K, Fowkes FGR, et al. Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health. 2019;7(8):e1020–30. First citation in articleCrossref Medline, Google Scholar

  • 2 Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382(9901):1329–40. First citation in articleCrossref Medline, Google Scholar

  • 3 Kreutzburg T, Peters F, Riess HC, Hischke S, Marschall U, Kriston L, et al. Editor’s Choice – Comorbidity patterns among patients with peripheral arterial occlusive disease in Germany: a trend analysis of health insurance claims data. Eur J Vasc Endovasc Surg. 2020;59(1):59–66. First citation in articleCrossref Medline, Google Scholar

  • 4 Behrendt CA, Nordanstig J, Do we need a war on amputations? A call to arms!. Eur J Vasc Endovasc Surg. 2022;63(1):156. First citation in articleCrossref Medline, Google Scholar

  • 5 Criqui MH, Matsushita K, Aboyans V, Hess CN, Hicks CW, Kwan TW, et al. Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American Heart Association. Circulation. 2021;144(9):e171–91. First citation in articleCrossref Medline, Google Scholar

  • 6 Aday AW, Matsushita K. Epidemiology of peripheral artery disease and polyvascular disease. Circ Res. 2021;128(12):1818–32. First citation in articleCrossref Medline, Google Scholar

  • 7 Lindholt JS, Søgaard R, Rasmussen LM, Mejldal A, Lambrechtsen J, Steffensen FH, et al. Five-year outcomes of the Danish Cardiovascular Screening (DANCAVAS) trial. N Engl J Med. 2022;387(15):1385–94. First citation in articleCrossref Medline, Google Scholar

  • 8 Behrendt C-A, Thomalla G, Rimmele DL, Petersen EL, Twerenbold R, Debus ES, et al. Prevalence of peripheral arterial disease, abdominal aortic aneurysm, and risk factors in the Hamburg City Health Study: a cross-sectional analysis. Eur J Vasc Endovasc Surg. 2023:S1078-5884(23)00004-7. First citation in articleMedline, Google Scholar

  • 9 Diehm C, Schuster A, Allenberg JR, Darius H, Haberl R, Lange S, et al. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis. 2004;172(1):95–105. First citation in articleCrossref Medline, Google Scholar

  • 10 Sigvant B, Lundin F, Wahlberg E. The risk of disease progression in peripheral arterial disease is higher than expected: a meta-analysis of mortality and disease progression in peripheral arterial disease. Eur J Vasc Endovasc Surg. 2016;51(3):395–403. First citation in articleCrossref Medline, Google Scholar

  • 11 Reinecke H, Unrath M, Freisinger E, Bunzemeier H, Meyborg M, Luders F, et al. Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherence. Eur Heart J. 2015;36(15):932–8. First citation in articleCrossref Medline, Google Scholar

  • 12 Makover ME, Shapiro MD, Toth PP. There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: A review of current practice and recommendations for improved effectiveness. Am J Prev Cardiol. 2022;12:100371. First citation in articleCrossref Medline, Google Scholar

  • 13 Aboyans V, Ricco JB, Bartelink MEL, Bjorck M, Brodmann M, Cohnert T, et al. Editor’s Choice – 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2018;55(3):305–68. First citation in articleCrossref Medline, Google Scholar

  • 14 Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. Eur J Vasc Endovasc Surg. 2019;58(1S):S1–S109.e33. First citation in articleCrossref Medline, Google Scholar

  • 15 Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, et al. 2016 AHA/ACC Guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;69(11):e71–126. First citation in articleCrossref Medline, Google Scholar

  • 16 Frank U, Nikol S, Belch J, Boc V, Brodmann M, Carpentier PH, et al. ESVM guideline on peripheral arterial disease. Vasa. 2019;48(Suppl 102):1–79. First citation in articleAbstract, Google Scholar

  • 17 Jones WS, Mi X, Qualls LG, Turley RS, Vemulapalli S, Peterson ED, et al. Significant variation in P2Y12 inhibitor use after peripheral vascular intervention in Medicare beneficiaries. Am Heart J. 2016;179:10–8. First citation in articleCrossref Medline, Google Scholar

  • 18 Kokkinidis DG, Arfaras-Melainis A, Giannopoulos S, Katsaros I, Jawaid O, Jonnalagadda AK, et al. Statin therapy for reduction of cardiovascular and limb-related events in critical limb ischemia: a systematic review and meta-analysis. Vasc Med. 2020;25(2):106–17. First citation in articleCrossref Medline, Google Scholar

  • 19 Peters F, Kreutzburg T, Riess HC, Heidemann F, Marschall U, L’Hoest H, et al. Editor’s Choice – Optimal pharmacological treatment of symptomatic peripheral arterial occlusive disease and evidence of female patient disadvantage: an analysis of health insurance claims data. Eur J Vasc Endovasc Surg. 2020;60(3):421–9. First citation in articleCrossref Medline, Google Scholar

  • 20 Subherwal S, Patel MR, Tang F, Smolderen KG, Jones WS, Tsai TT, et al. Socioeconomic disparities in the use of cardioprotective medications among patients with peripheral artery disease: an analysis of the American College of Cardiology’s NCDR PINNACLE Registry. J Am Coll Cardiol. 2013;62(1):51–7. First citation in articleCrossref Medline, Google Scholar

  • 21 Pastori D, Farcomeni A, Milanese A, Del Sole F, Menichelli D, Hiatt WR, et al. Statins and major adverse limb events in patients with peripheral artery disease: a systematic review and meta-analysis. Thromb Haemost. 2020;120(5):866–75. First citation in articleCrossref Medline, Google Scholar

  • 22 Arya S, Khakharia A, Binney ZO, DeMartino RR, Brewster LP, Goodney PP, et al. Association of statin dose with amputation and survival in patients with peripheral artery disease. Circulation. 2018;137(14):1435–46. First citation in articleCrossref Medline, Google Scholar

  • 23 Alushi K, Hinterseher I, Peters F, Rother U, Bischoff MS, Mylonas S, et al. Distribution of mobile health applications amongst patients with symptomatic peripheral arterial disease in Germany: a cross-sectional survey study. J Clin Med. 2022;11(3):498. First citation in articleCrossref Medline, Google Scholar

  • 24 Wolbert L, Kreutzburg T, Zyriax BC, Adegbola A, Westenhöfer J, Jagemann B, et al. A cross-sectional survey study on the nutrition patterns of patients with peripheral artery disease. Vasa. 2022;51(4):239–46. First citation in articleLink, Google Scholar

  • 25 Pande RL, Perlstein TS, Beckman JA, Creager MA. Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999 to 2004. Circulation. 2011;124(1):17–23. First citation in articleCrossref Medline, Google Scholar

  • 26 Berger JS, Ladapo JA. Underuse of prevention and lifestyle counseling in patients with peripheral artery disease. J Am Coll Cardiol. 2017;69(18):2293–300. First citation in articleCrossref Medline, Google Scholar

  • 27 Londero LS, Høgh A, Houlind K, Lindholt JS. Danish trends in major amputation after vascular reconstruction in patients with peripheral arterial disease 2002–2014. Eur J Vasc Endovasc Surg. 2019;57(1):111–20. First citation in articleCrossref Medline, Google Scholar

  • 28 Creager MA, Matsushita K, Arya S, Beckman JA, Duval S, Goodney PP, et al. Reducing nontraumatic lower-extremity amputations by 20% by 2030: time to get to our feet: a policy statement from the American Heart Association. Circulation. 2021;143(17):e875–91. First citation in articleCrossref Medline, Google Scholar

  • 29 Bridgwood BM, Nickinson AT, Houghton JS, Pepper CJ, Sayers RD. Knowledge of peripheral artery disease: What do the public, healthcare practitioners, and trainees know? Vasc Med. 2020;25(3):263–73. First citation in articleCrossref Medline, Google Scholar

  • 30 McDermott MM, Mandapat AL, Moates A, Albay M, Chiou E, Celic L, et al. Knowledge and attitudes regarding cardiovascular disease risk and prevention in patients with coronary or peripheral arterial disease. Arch Intern Med. 2003;163(18):2157–62. First citation in articleCrossref Medline, Google Scholar

  • 31 Builyte IU, Baltrunas T, Butkute E, Srinanthalogen R, Skrebunas A, Urbonavicius S, et al. Peripheral artery disease patients are poorly aware of their disease. Scand Cardiovasc J. 2019;53(6):373–8. First citation in articleCrossref Medline, Google Scholar

  • 32 Pande RL, Creager MA. Socioeconomic inequality and peripheral artery disease prevalence in US adults. Circ Cardiovasc Qual Outcomes. 2014;7(4):532–9. First citation in articleCrossref Medline, Google Scholar